Yuichi Kamikubo, PhD
Coagulation Program Leader
Dr. Yuichi Kamikubo earned his master’s degree in Biological Chemistry from the Kagoshima University Graduate School of Science and Engineering, Japan, followed by his Ph.D. in Pharmaceutical Sciences (Biochemistry) from Nagasaki University, Japan. For nearly 25 years, Dr. Kamikubo has studied the underlying mechanisms for blood coagulation in pharmaceutical (Chemo-Sero-Therapeutic Research Institute, Japan) and academic arenas (The Scripps Research Institute, La Jolla, CA). His work led to the discovery of a previously-unrecognized coagulation mechanism involving a coagulation initiator tissue factor. Dr. Kamikubo joined MERU VasImmune in 2017 and is currently developing novel methods, components, and devices of global and laboratory coagulation assays for a more precise diagnosis of thrombosis and bleeding in special patient populations. Establishing new assay methods can provide useful approaches for identifying and characterizing the new hemostatic and antithrombotic drugs with improved therapeutic efficacy.